The Patentability of Synthetic Biology Inventions: New Technology, Same Patentability Issues?
Autor Ilaria de Lisaen Limba Engleză Hardback – 29 sep 2020
The book addresses this question, focusing especially on the subject matter’s eligibility and moral criteria. It provides an overview of the legislation and decisions applicable to SynBio patents and examines this new technology in view of the ongoing debate over the patentability of biotechnologies in general.
The legal analysis is complemented by the practical examination of several patent applications submitted to the European and US patent offices (EPO and USPTO), and by an assessment of the patent issues that are likely to be raised by future SynBio developments.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 644.50 lei 39-44 zile | |
Springer International Publishing – 30 sep 2021 | 644.50 lei 39-44 zile | |
Hardback (1) | 654.28 lei 39-44 zile | |
Springer International Publishing – 29 sep 2020 | 654.28 lei 39-44 zile |
Preț: 654.28 lei
Preț vechi: 860.90 lei
-24%
Puncte Express: 981
Preț estimativ în valută:
125.35€ • 136.09$ • 107.50£
125.35€ • 136.09$ • 107.50£
Carte tipărită la comandă
Livrare economică 06-11 mai
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030512057
ISBN-10: 3030512053
Ilustrații: XIV, 323 p. 1 illus.
Dimensiuni: 155 x 235 mm
Greutate: 0.65 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030512053
Ilustrații: XIV, 323 p. 1 illus.
Dimensiuni: 155 x 235 mm
Greutate: 0.65 kg
Ediția:1st ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Introduction.- Synthetic Biology.- Norms And Patents In The Field Of Synthetic Biology.- The Patent Eligibility Of Synthetic Biology Inventions.- The Morality Of Synthetic Biology Inventions.- Perspectives And Conclusions.- Conclusions.
Notă biografică
Dr. Ilaria de Lisa is a Lawyer at Gleiss Lutz.
Textul de pe ultima copertă
This book addresses Synthetic Biology (SynBio), a new and promising biotechnology that has attracted much interest from both a scientific and a policy perspective. Yet, questions concerning the patentability of SynBio inventions have not been examined in detail so far; as a result, it remains unclear whether these inventions are patentable on the basis of current norms and case law.
The book addresses this question, focusing especially on the subject matter’s eligibility and moral criteria. It provides an overview of the legislation and decisions applicable to SynBio patents and examines this new technology in view of the ongoing debate over the patentability of biotechnologies in general.
The book addresses this question, focusing especially on the subject matter’s eligibility and moral criteria. It provides an overview of the legislation and decisions applicable to SynBio patents and examines this new technology in view of the ongoing debate over the patentability of biotechnologies in general.
The legal analysis is complemented by the practical examination of several patent applications submitted to the European and US patent offices (EPO and USPTO), and by an assessment of the patent issues that are likely to be raised by future SynBio developments.
Caracteristici
First book to ever discuss in detail the patentability of SynBio inventions
Offers a complete overview of the patent issues raised by SynBio inventions (covers the eligibility, morality, novelty and inventiveness criteria)
Discusses and compares the approaches in Europe and the US jurisdiction
Reviews the actual examination process of several SynBio patent applications filed in Europe (EPO) and the US (USPTO) and compares the two
Offers a complete overview of the patent issues raised by SynBio inventions (covers the eligibility, morality, novelty and inventiveness criteria)
Discusses and compares the approaches in Europe and the US jurisdiction
Reviews the actual examination process of several SynBio patent applications filed in Europe (EPO) and the US (USPTO) and compares the two